Cargando…
Decrease in serum levels of autotaxin in COVID-19 patients
INTRODUCTION: In order to identify therapeutic targets in Coronavirus disease 2019 (COVID-19), it is important to identify molecules involved in the biological responses that are modulated in COVID-19. Lysophosphatidic acids (LPAs) are involved in the pulmonary inflammation and fibrosis are one of t...
Autores principales: | Shimura, Takuya, Kurano, Makoto, Okamoto, Koh, Jubishi, Daisuke, Hashimoto, Hideki, Kano, Kuniyuki, Igarashi, Koji, Shimamoto, Satoshi, Aoki, Junken, Moriya, Kyoji, Yatomi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665086/ https://www.ncbi.nlm.nih.gov/pubmed/36369824 http://dx.doi.org/10.1080/07853890.2022.2143554 |
Ejemplares similares
-
Increase in serum levels of phosphatidylserine-specific phospholipase A(1) in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2021) -
Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018) -
Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
por: Kurano, Makoto, et al.
Publicado: (2022) -
Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
por: Kurano, Makoto, et al.
Publicado: (2022) -
Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
por: Uranbileg, Baasanjav, et al.
Publicado: (2021)